載入...
Treatment with Ramucirumab-paclitaxel in a metastatic gastric cancer patient undergoing hemodialysis: A case report
RATIONALE: Ramucirumab, a human Ig 1 monoclonal antibody against vascular endothelial growth factor receptor-2, in combination with paclitaxel is a second-line chemotherapy for patients with metastatic gastric cancer. Several reports have suggested that dose adjustments of cetuximab, an anti- epider...
Na minha lista:
| 發表在: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Lippincott Williams & Wilkins
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7899881/ https://ncbi.nlm.nih.gov/pubmed/33607838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000024795 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|